Experimental medicine stage one supports academic researchers conducting human intervention studies to understand disease mechanisms and identify paths towards future treatments or diagnostics.
UKRI translation: MRC proof of concept: stage two supports academic teams developing and testing medical interventions and research tools to address significant health needs and deliver patient benefit.
Invite only: Precision prevention: biological mechanisms of response variation supports research teams studying human biological responses to biomedical prevention to improve its targeting, timing and delivery.
UKRI Translation: MRC Proof of Concept: stage one supports academic teams developing and testing medical interventions and research tools to address significant health needs and advance patient benefit.
MRC: research grant: applicant-led supports research teams pursuing discovery and early translational studies to understand human health and disease, improve diagnosis, advance treatment and prevent illness.